Radaeva S, Ferreira-Gonzalez A, Sirica A E
Department of Pathology, Medical College of Virginia Campus of Virginia Commonwealth University, Richmond, VA 23298-0297, USA.
Hepatology. 1999 May;29(5):1453-62. doi: 10.1002/hep.510290524.
Based on limited but compelling immunohistochemical data demonstrating individual overexpression of the tyrosine kinase growth factor receptors, c-erbB-2 and c-met, in significant percentages of human cholangiocarcinoma (ChC), we investigated if combined overexpression of both c-neu, the rat homologue of c-erbB-2, and c-met, the receptor for hepatocyte growth factor/scatter factor (HGF/SF), might represent a characteristic, early event associated with furan-induced cholangiocarcinogenesis in rat liver. Specifically, through the use of immunohistochemistry, in situ hybridization (ISH), and Western and Northern blotting, we found that both c-neu and c-met are prominently overexpressed in intestinal metaplastic lesions in early putative precancerous cholangiofibrotic tissue formed in the livers of rats after 6 weeks of furan treatment when compared with normal and hyperplastic intrahepatic biliary epithelia. We further demonstrated that c-neu and c-met are concordantly overexpressed in neoplastic glandular epithelia in later-developed primary "intestinal-type" of ChC formed in the livers of furan-treated rats, as well as in subsequently derived transplantable mucin-producing tumors. Overexpression of c-neu and c-met correlated with increased proliferating cell nuclear antigen (PCNA)-labeling indices, which were determined to be three to four times higher in intestinal metaplastic glands in precancerous cholangiofibrotic tissue and in neoplastic glands in the primary "intestinal type" of ChC than in hyperplastic bile ductular structures within either cholangiofibrotic or bile duct-ligated (BDL) livers. The c-neu and c-met receptor proteins overexpressed in different in vivo passages of a transplantable ChC each contained immunoreactive phosphotyrosines, indicating an activated state. However, we did not detect evidence of either gene amplification of c-neu or c-met or of a common transmembrane-activating mutation in c-neu expressed in transplantable ChC. Our findings indicate that altered expression of c-neu and c-met occurs relatively early in the process of furan-induced cholangiocarcinogenesis in rat liver and may play a potentially important role in its pathogenesis. They further indicate a common alteration in tyrosine kinase growth factor receptor expression linking early putative precancerous intestinal metaplastic lesions in liver to later-developed mucin-producing biliary cancer.
基于有限但令人信服的免疫组织化学数据,这些数据表明酪氨酸激酶生长因子受体c-erbB-2和c-met在相当比例的人类胆管癌(ChC)中存在个体过表达,我们研究了c-neu(c-erbB-2的大鼠同源物)和c-met(肝细胞生长因子/散射因子(HGF/SF)的受体)的联合过表达是否可能代表与呋喃诱导的大鼠肝癌变相关的一个特征性早期事件。具体而言,通过使用免疫组织化学、原位杂交(ISH)以及蛋白质免疫印迹和Northern印迹,我们发现与正常和增生性肝内胆管上皮相比,在呋喃处理6周后大鼠肝脏中形成的早期假定癌前胆管纤维化组织中的肠化生病变中,c-neu和c-met均显著过表达。我们进一步证明,在呋喃处理的大鼠肝脏中形成的后期原发性“肠型”ChC的肿瘤性腺上皮中,以及在随后衍生的可移植产粘蛋白肿瘤中,c-neu和c-met一致过表达。c-neu和c-met的过表达与增殖细胞核抗原(PCNA)标记指数增加相关,在癌前胆管纤维化组织中的肠化生腺体以及原发性“肠型”ChC的肿瘤性腺体中,PCNA标记指数比胆管纤维化或胆管结扎(BDL)肝脏中的增生性胆管结构高三到四倍。在可移植ChC的不同体内传代中过表达的c-neu和c-met受体蛋白均含有免疫反应性磷酸酪氨酸,表明处于激活状态。然而,我们未检测到可移植ChC中c-neu或c-met基因扩增的证据,也未检测到c-neu中常见的跨膜激活突变。我们的研究结果表明,c-neu和c-met的表达改变在呋喃诱导的大鼠肝癌变过程中相对较早发生,可能在其发病机制中发挥潜在重要作用。它们进一步表明酪氨酸激酶生长因子受体表达的共同改变将肝脏中早期假定的癌前肠化生病变与后期形成的产粘蛋白胆管癌联系起来。